Paul Horstmeier, Chief Operating Officer at Health Catalyst, Inc. (HCAT), sold 21,500 shares at $57.19 ($1.2M) on 2021-07-06, disclosed to the SEC on 2021-07-08.
Open-market sale of $1.2M HCAT by Chief Operating Officer. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $56.69 | 4,058 | $230K | 18.8% |
| 2 | $56.69 | 4,058 | $230K | 18.8% |
| 3 | $57.19 | 6,692 | $383K | 31.2% |
| 4 | $57.19 | 6,692 | $383K | 31.2% |
| Total | $57.00 avg | 21,500 | $1.2M | 100% |
| Filing → |
| HCAT | SELL | 2022-03-11 | $587K | — | Filing → |
| HCAT | SELL | 2022-02-09 | $626K | — | Filing → |
| HCAT | SELL | 2022-01-06 | $791K | — | Filing → |